Hinge Health (NASDAQ: HNGE) chair sells 33,333 shares under 10b5-1

Rhea-AI Filing Summary

Hinge Health, Inc. executive chairman and co-founder Gabriel M.I. Mecklenburg reported an insider transaction involving a conversion and sale of shares. He converted 33,333 shares of Class B Common Stock into Class A Common Stock and then sold 33,333 Class A shares in an open-market transaction at a weighted average price of $45.0463 per share, with prices ranging from $45.00 to $45.44, under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025. After these transactions, he reported direct ownership of 1,759,769 shares of Class B Common Stock and indirect Class B holdings convertible into 383,592 Class A shares through a family trust and 1,092,119 Class A shares through a GRAT, plus an additional 944,250 performance stock units that are excluded from the reported amounts.

Insider Trade Summary 10b5-1

Net Seller: 33,333 shares ($1,501,528)

Net Sell 5 txns

Insider Mecklenburg Gabriel M.I.

Role null

Sold 33,333 shs ($1.50M)

Type	Security	Shares	Price	Value
Conversion	Class B Common Stock	33,333	$0.00	--
Conversion	Class A Common Stock	33,333	$0.00	--
Sale	Class A Common Stock	33,333	$45.0463	$1.50M
holding	Class B Common Stock	--	--	--
holding	Class B Common Stock	--	--	--

Holdings After Transaction: Class B Common Stock — 1,759,769 shares (Direct, null); Class A Common Stock — 33,333 shares (Direct, null); Class B Common Stock — 1,092,119 shares (Indirect, By GRAT)

Footnotes (1)

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025. Represents the weighted average sale price. The lowest price at which shares were sold was $45.00 and the highest price at which shares were sold was $45.44. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein. Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation. Excludes 944,250 performance stock units held by the Reporting Person.

Key Figures

Shares sold: 33,333 shares Weighted average sale price: $45.0463 per share Net shares sold: 33,333 shares +5 more

8 metrics

Shares sold 33,333 shares Class A Common Stock open-market sale

Weighted average sale price $45.0463 per share Class A sale price range $45.00–$45.44

Net shares sold 33,333 shares transactionSummary netBuySellShares

Direct Class B holdings 1,759,769 shares Total shares following derivative transaction

Family trust underlying shares 383,592 shares Class B convertible into Class A via family trust

GRAT underlying shares 1,092,119 shares Class B convertible into Class A via GRAT

Excluded performance stock units 944,250 units Performance stock units held but excluded from totals

Exercise price of Class B $0.0000 Conversion of Class B into Class A

Key Terms

Rule 10b5-1 trading plan, Class B Common Stock, Class A Common Stock, GRAT, +1 more

5 terms

Rule 10b5-1 trading plan financial

"The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Class B Common Stock financial

"Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock"

A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.

Class A Common Stock financial

"Each share of Class B Common Stock is convertible into one share of the Issuer's Class A Common Stock"

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

GRAT financial

""nature_of_ownership": "By GRAT""

performance stock units financial

"Excludes 944,250 performance stock units held by the Reporting Person."

Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mecklenburg Gabriel M.I.

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CALIFORNIA 94105

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Exec. Chairman & Co-Founder

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/21/2026		C		33,333	A	$0	33,333	D
Class A Common Stock	04/21/2026		S(1)		33,333	D	$45.0463(2)	0	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Class B Common Stock	(3)	04/21/2026		C			33,333	(3)	(3)	Class A Common Stock	33,333	$0	1,759,769(4)	D
Class B Common Stock	(3)							(3)	(3)	Class A Common Stock	1,092,119		1,092,119	I	By GRAT
Class B Common Stock	(3)							(3)	(3)	Class A Common Stock	383,592		383,592	I	By Family Trust

Explanation of Responses:

1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 1, 2025.

2. Represents the weighted average sale price. The lowest price at which shares were sold was $45.00 and the highest price at which shares were sold was $45.44. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.

3. Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.

4. Excludes 944,250 performance stock units held by the Reporting Person.

	/s/ James Budge, Attorney-in-Fact	04/22/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HNGE executive Gabriel Mecklenburg report?

Gabriel Mecklenburg reported converting and selling 33,333 Hinge Health Class A shares. The sale was executed at a weighted average price of $45.0463 per share under a pre-arranged Rule 10b5-1 trading plan adopted on December 1, 2025.

At what price did HNGE insider shares trade in this Form 4 filing?

The reported HNGE insider sale used a weighted average price of $45.0463 per share. Individual trades occurred between $45.00 and $45.44, and the reporting person offered to provide detailed trade breakdowns upon request to regulators or shareholders.

How many HNGE shares did Gabriel Mecklenburg sell in this transaction?

Gabriel Mecklenburg sold 33,333 shares of Hinge Health Class A Common Stock. These shares were first obtained by converting an equal number of Class B shares, then sold in open-market trades pursuant to his established Rule 10b5-1 trading plan.

What HNGE holdings does Gabriel Mecklenburg report after this Form 4?

Following the reported trades, Mecklenburg directly holds 1,759,769 Class B shares. He also has indirect Class B interests convertible into 383,592 Class A shares via a family trust and 1,092,119 Class A shares via a GRAT, plus excluded performance stock units.

What does the Rule 10b5-1 plan mean for this HNGE insider sale?

The filing states the sale occurred under a Rule 10b5-1 trading plan adopted on December 1, 2025. Such plans pre-schedule trades, indicating the timing of this 33,333-share sale was set in advance rather than decided opportunistically.